|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Allocation of net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: | ||
| Dividend income earned on cash and investment held in trust account | ||
| Change in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Due to Sponsor – related party | ||
| Accrued liabilities | ||
| Net cash (used in) provided by operating activities | ||
| Cash flows from investing activities: | ||
| Proceeds deposited in Trust Account | ||
| Net cash used in investing activities | ||
| Advance from related party | ||
| Advance from related party | ||
| Proceed from public offering, net of offering costs | ||
| Proceed from private placement | ||
| Net cash provided by financing activities | ||
| NET CHANGE IN CASH | ||
| CASH, BEGINNING OF YEAR | ||
| CASH, END OF YEAR | ||
| Reconciliation to amounts on balance sheets: | ||
| Cash | ||
| Cash in escrow | ||
| Total cash and cash in escrow balance | ||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
| Issuance of representative shares | ||
| Initial classification of ordinary shares subject to possible redemption | ||
| Allocation of offering costs to ordinary shares subject to possible redemption | ||
| Accretion of carrying value to redemption value | ||
| Subsequent remeasurement of ordinary shares subject to possible redemption | ||
| Accrued underwriting compensation |
Loading...
